140 related articles for article (PubMed ID: 17353095)
1. Cholesterol level, statin use and Alzheimer's disease in adults with Down syndrome.
Zigman WB; Schupf N; Jenkins EC; Urv TK; Tycko B; Silverman W
Neurosci Lett; 2007 Apr; 416(3):279-84. PubMed ID: 17353095
[TBL] [Abstract][Full Text] [Related]
2. Lower risk of Alzheimer's disease mortality with exercise, statin, and fruit intake.
Williams PT
J Alzheimers Dis; 2015; 44(4):1121-9. PubMed ID: 25408208
[TBL] [Abstract][Full Text] [Related]
3. Cholesterol, statins, and longevity from age 70 to 90 years.
Jacobs JM; Cohen A; Ein-Mor E; Stessman J
J Am Med Dir Assoc; 2013 Dec; 14(12):883-8. PubMed ID: 24094647
[TBL] [Abstract][Full Text] [Related]
4. Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study.
Haag MD; Hofman A; Koudstaal PJ; Stricker BH; Breteler MM
J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):13-7. PubMed ID: 18931004
[TBL] [Abstract][Full Text] [Related]
5. Re-assessing the relationship between cholesterol, statins and Alzheimer's disease.
Wolozin B; Manger J; Bryant R; Cordy J; Green RC; McKee A
Acta Neurol Scand Suppl; 2006; 185():63-70. PubMed ID: 16866913
[TBL] [Abstract][Full Text] [Related]
6. Bioavailable estradiol and age at onset of Alzheimer's disease in postmenopausal women with Down syndrome.
Schupf N; Winsten S; Patel B; Pang D; Ferin M; Zigman WB; Silverman W; Mayeux R
Neurosci Lett; 2006 Oct; 406(3):298-302. PubMed ID: 16926067
[TBL] [Abstract][Full Text] [Related]
7. Relation between cholesterol levels, statins and Alzheimer's disease in the human population.
Austen B; Christodoulou G; Terry JE
J Nutr Health Aging; 2002; 6(6):377-82. PubMed ID: 12459888
[TBL] [Abstract][Full Text] [Related]
8. Statins and dementia.
Kuller LH
Curr Atheroscler Rep; 2007 Aug; 9(2):154-61. PubMed ID: 17877925
[TBL] [Abstract][Full Text] [Related]
9. Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.
Zandi PP; Sparks DL; Khachaturian AS; Tschanz J; Norton M; Steinberg M; Welsh-Bohmer KA; Breitner JC;
Arch Gen Psychiatry; 2005 Feb; 62(2):217-24. PubMed ID: 15699299
[TBL] [Abstract][Full Text] [Related]
10. Do statins prevent Alzheimer's disease? A narrative review.
Daneschvar HL; Aronson MD; Smetana GW
Eur J Intern Med; 2015 Nov; 26(9):666-9. PubMed ID: 26342722
[TBL] [Abstract][Full Text] [Related]
11. Reduced risk of incident AD with elective statin use in a clinical trial cohort.
Sparks DL; Kryscio RJ; Sabbagh MN; Connor DJ; Sparks LM; Liebsack C
Curr Alzheimer Res; 2008 Aug; 5(4):416-21. PubMed ID: 18690839
[TBL] [Abstract][Full Text] [Related]
12. Statins: drugs for Alzheimer's disease?
Eckert GP; Wood WG; Müller WE
J Neural Transm (Vienna); 2005 Aug; 112(8):1057-71. PubMed ID: 15682268
[TBL] [Abstract][Full Text] [Related]
13. Statins, incident Alzheimer disease, change in cognitive function, and neuropathology.
Arvanitakis Z; Schneider JA; Wilson RS; Bienias JL; Kelly JF; Evans DA; Bennett DA
Neurology; 2008 May; 70(19 Pt 2):1795-802. PubMed ID: 18199831
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol and statins in Alzheimer's disease: current controversies.
Fonseca AC; Resende R; Oliveira CR; Pereira CM
Exp Neurol; 2010 Jun; 223(2):282-93. PubMed ID: 19782682
[TBL] [Abstract][Full Text] [Related]
15. How statins could be evaluated successfully in clinical trials for Alzheimer's disease?
Burgos JS; Benavides J; Douillet P; Velasco J; Valdivieso F
Am J Alzheimers Dis Other Demen; 2012 May; 27(3):151-3. PubMed ID: 22510498
[TBL] [Abstract][Full Text] [Related]
16. Relation of serum total cholesterol, C-reactive protein levels, and statin therapy to survival in heart failure.
May HT; Muhlestein JB; Carlquist JF; Horne BD; Bair TL; Campbell BA; Kfoury AG; Lyon JL; Kim H; Renlund DG
Am J Cardiol; 2006 Sep; 98(5):653-8. PubMed ID: 16923455
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol and cognitive performance in normal controls and the influence of elective statin use after conversion to mild cognitive impairment: results in a clinical trial cohort.
Sparks DL; Kryscio RJ; Connor DJ; Sabbagh MN; Sparks LM; Lin Y; Liebsack C
Neurodegener Dis; 2010; 7(1-3):183-6. PubMed ID: 20224282
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol-modifying strategies for Alzheimer's disease.
Solomon A; Kivipelto M
Expert Rev Neurother; 2009 May; 9(5):695-709. PubMed ID: 19402779
[TBL] [Abstract][Full Text] [Related]
19. Low cholesterol levels are associated with a high mortality risk in older adults without statins therapy: An externally validated cohort study.
Turusheva A; Vaes B; Degryse JM; Frolova E
Arch Gerontol Geriatr; 2020; 90():104180. PubMed ID: 32688205
[TBL] [Abstract][Full Text] [Related]
20. Effect of statins on beta-amyloid metabolism in humans: potential importance for the development of senile plaques in Alzheimer's disease.
Höglund K; Wallin A; Blennow K
Acta Neurol Scand Suppl; 2006; 185():87-92. PubMed ID: 16866916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
